A low-grade fever might develop
In trials like STEP 1, semaglutide users lost 14.9% of body weight over 68 weeks versus 2.4% on placebo.[3][4][5][1] These medications excel in obesity and type 2 diabetes management, with average losses of 15-25% body weight after a year
Do not assume compatibility with third-party, unverified, or non-Peptiology peptide batches
Between January 2024 and June 2025, first-time prescribing increased at an average rate of 0.01 percentage points per month, a 239% gain over the period
Families shared their children felt lighter and more settled day to day
When people talk about peptides for skin health, hair growth, and recovery, one name comes up consistently: GHK-Cu, often referred to as the glow peptide